BMJ 2008;336:924-926 (26 April), doi:10.1136/bmj.39489.470347.AD
Analysis
Rating quality of evidence and strength of recommendations
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H Guyatt, professor1,
Andrew D Oxman, researcher2,
Gunn E Vist, researcher2,
Regina Kunz, associate professor3,
Yngve Falck-Ytter, assistant professor4,
Pablo Alonso-Coello, researcher5,
Holger J Schünemann, professor6, for the GRADE Working Group
1 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada L8N 3Z5,
2 Norwegian Knowledge Centre for the Health Services, PO Box 7004, St Olavs Plass, 0130 Oslo, Norway,
3 Basel Institute of Clinical Epidemiology, University Hospital Basel, Hebelstrasse 10, 4031 Basel, Switzerland,
4 Division of Gastroenterology, Case Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA,
5 Iberoamerican Cochrane Center, Servicio de Epidemiología Clínica y Salud Pública (Universidad Autónoma de Barcelona), Hospital de Sant Pau, Barcelona 08041, Spain ,
6 Department of Epidemiology, Italian National Cancer Institute Regina Elena, Rome, Italy
Correspondence to: G H Guyatt, CLARITY Research Group, Department of Clinical Epidemiology and Biostatistics, Room 2C12, 1200 Main Street, West Hamilton, ON, Canada L8N 3Z5 guyatt@mcmaster.ca
Guidelines are inconsistent in how they rate the quality of evidence and the strength of recommendations. This article explores the advantages of the GRADE system, which is increasingly being adopted by organisations worldwide
| The first 150 words of the full text of this article appear below. |
- Failure to consider the quality of evidence can lead to misguided recommendations; hormone replacement therapy for post-menopausal women provides an instructive example
- High quality evidence that an interventions desirable effects are clearly greater than its undesirable effects, or are clearly not, warrants a strong recommendation
- Uncertainty about the trade-offs (because of low quality evidence or because the desirable and undesirable effects are closely balanced) warrants a weak recommendation
- Guidelines should inform clinicians what the quality of the underlying evidence is and whether recommendations are strong or weak
- The Grading of Recommendations Assessment, Development and Evaluation (GRADE ) approach provides a system for rating quality of evidence and strength of recommendations that is explicit, comprehensive, transparent, and pragmatic and is increasingly being adopted by organisations worldwide
| |
Guideline developers around the world are inconsistent in how they rate quality of evidence and grade strength of recommendations. As a result, guideline users face . . . [Full text of this article]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Relevant Articles
-
Adjunctive non-invasive ways of healing bone fractures
- Rudolf W Poolman
BMJ 2009 338: b11.
[Extract]
[Full Text]
-
Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive
- Roman Jaeschke, Gordon H Guyatt, Phil Dellinger, Holger Schünemann, Mitchell M Levy, Regina Kunz, Susan Norris, Julian Bion for the GRADE working group
BMJ 2008 337: a744.
[Extract]
[Full Text]
-
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies
- Holger J Schünemann, Andrew D Oxman, Jan Brozek, Paul Glasziou, Roman Jaeschke, Gunn E Vist, John W Williams, Jr, Regina Kunz, Jonathan Craig, Victor M Montori, Patrick Bossuyt, Gordon H Guyatt for the GRADE Working Group
BMJ 2008 336: 1106-1110.
[Extract]
[Full Text]
[PDF]
-
Going from evidence to recommendations
- Gordon H Guyatt, Andrew D Oxman, Regina Kunz, Yngve Falck-Ytter, Gunn E Vist, Alessandro Liberati, Holger J Schünemann for the GRADE Working Group
BMJ 2008 336: 1049-1051.
[Extract]
[Full Text]
[PDF]
-
Reduce, reuse, recycle
- Trish Groves
BMJ 2008 336: 0.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Annane, D., Bellissant, E., Bollaert, P.-E., Briegel, J., Confalonieri, M., De Gaudio, R., Keh, D., Kupfer, Y., Oppert, M., Meduri, G. U.
(2009). Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review. JAMA
301: 2362-2375
[Abstract]
[Full text]
-
Jaeschke, R., Angus, D. C.
(2009). Living With Uncertainty in the Intensive Care Unit: Should Patients With Sepsis Be Treated With Steroids?. JAMA
301: 2388-2390
[Full text]
-
Vanholder, R., Abramowicz, D., Cannata-Andia, J. B., Cocchi, V., Cochat, P., Covic, A., Eckardt, K.-U., Fouque, D., Heimburger, O., Jenkins, S., MacLeod, A., Lindley, E., Locatelli, F., London, G., Marti i Monros, A., Spasovski, G., Tattersall, J., Van Biesen, W., Wanner, C., Wiecek, A., Zoccali, C.
(2009). The future of European Nephrology 'Guidelines'--a declaration of intent by European Renal Best Practice (ERBP). NDT Plus
2: 213-221
[Full text]
-
Scott, P., Huss, A., Stuck, A. E., Trotter, C., Egger, M.
(2009). Efficacy of pneumococcal polysaccharide vaccine. CMAJ
180: 1134-1135
[Full text]
-
Howick, J., Glasziou, P., Aronson, J. K
(2009). The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?. JRSM
102: 186-194
[Full text]
-
Melmed, S., Colao, A., Barkan, A., Molitch, M., Grossman, A. B., Kleinberg, D., Clemmons, D., Chanson, P., Laws, E., Schlechte, J., Vance, M. L., Ho, K., Giustina, A.
(2009). Guidelines for Acromegaly Management: An Update. J. Clin. Endocrinol. Metab.
94: 1509-1517
[Abstract]
[Full text]
-
Horvath, A. R.
(2009). Grading Quality of Evidence and Strength of Recommendations for Diagnostic Tests and Strategies. Clin. Chem.
55: 853-855
[Full text]
-
Poolman, R. W
(2009). Adjunctive non-invasive ways of healing bone fractures. BMJ
338: b11-b11
[Full text]
-
Alonso-Coello, P., Lopez, A., Pencille, L. J., Montori, V. M.
(2009). Is Too Much Intervention Recommended in the ACP Osteoporosis Treatment Guidelines?. ANN INTERN MED
150: 285-286
[Full text]
-
Murad, M. H., Montori, V. M., Guyatt, G. H.
(2008). Incorporating Patient Preferences in Evidence-Based Medicine. JAMA
300: 2483-2483
[Full text]
-
Erstad, B. L
(2008). A Primer on Critical Care Pharmacy Services. The Annals of Pharmacotherapy
42: 1871-1881
[Abstract]
[Full text]
-
Neumann, P. J., Kamae, M. S., Palmer, J. A.
(2008). Medicare's National Coverage Decisions For Technologies, 1999-2007. Health Aff (Millwood)
27: 1620-1631
[Abstract]
[Full text]
-
Montori, V. M., Guyatt, G. H.
(2008). Progress in Evidence-Based Medicine. JAMA
300: 1814-1816
[Full text]
-
Jaeschke, R., Guyatt, G. H, Dellinger, P., Schunemann, H., Levy, M. M, Kunz, R., Norris, S., Bion, J., for the GRADE working group,
(2008). Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ
337: a744-a744
[Full text]